Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat

Saki Yajima, Hirohito Shionoya, Takashi Akagi, Keita Hamasaki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Neamine derivatives bearing a nucleobase, adenine, cytosine, guanine or thymine with a lysine or an arginine as a linker have been synthesized and its potential as the inhibitor for HIV TAR-Tat interaction examined. Among them, modified neamine having an arginine-nucleobase showed a higher inhibition than that of the one having a lysine-nucleobase. The difference of the nucleobase anchor did not characterize inhibition specificity. Also, stereochemistry of the amino acid in the compounds causes no difference in the inhibition for TAR-Tat.

Original languageEnglish
Pages (from-to)2799-2809
Number of pages11
JournalBioorganic and Medicinal Chemistry
Volume14
Issue number8
DOIs
Publication statusPublished - 2006 Apr 15

Fingerprint

Lysine
Arginine
Bearings (structural)
Derivatives
Stereochemistry
Thymine
Cytosine
Guanine
Adenine
Anchors
Amino Acids
neamine

Keywords

  • Aminoglycoside
  • Drug design
  • HIV TAR
  • HIV Tat
  • Inhibition
  • Neamine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat. / Yajima, Saki; Shionoya, Hirohito; Akagi, Takashi; Hamasaki, Keita.

In: Bioorganic and Medicinal Chemistry, Vol. 14, No. 8, 15.04.2006, p. 2799-2809.

Research output: Contribution to journalArticle

@article{82b6164be32d4744b41f1d487b26bc7e,
title = "Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat",
abstract = "Neamine derivatives bearing a nucleobase, adenine, cytosine, guanine or thymine with a lysine or an arginine as a linker have been synthesized and its potential as the inhibitor for HIV TAR-Tat interaction examined. Among them, modified neamine having an arginine-nucleobase showed a higher inhibition than that of the one having a lysine-nucleobase. The difference of the nucleobase anchor did not characterize inhibition specificity. Also, stereochemistry of the amino acid in the compounds causes no difference in the inhibition for TAR-Tat.",
keywords = "Aminoglycoside, Drug design, HIV TAR, HIV Tat, Inhibition, Neamine",
author = "Saki Yajima and Hirohito Shionoya and Takashi Akagi and Keita Hamasaki",
year = "2006",
month = "4",
day = "15",
doi = "10.1016/j.bmc.2005.11.056",
language = "English",
volume = "14",
pages = "2799--2809",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat

AU - Yajima, Saki

AU - Shionoya, Hirohito

AU - Akagi, Takashi

AU - Hamasaki, Keita

PY - 2006/4/15

Y1 - 2006/4/15

N2 - Neamine derivatives bearing a nucleobase, adenine, cytosine, guanine or thymine with a lysine or an arginine as a linker have been synthesized and its potential as the inhibitor for HIV TAR-Tat interaction examined. Among them, modified neamine having an arginine-nucleobase showed a higher inhibition than that of the one having a lysine-nucleobase. The difference of the nucleobase anchor did not characterize inhibition specificity. Also, stereochemistry of the amino acid in the compounds causes no difference in the inhibition for TAR-Tat.

AB - Neamine derivatives bearing a nucleobase, adenine, cytosine, guanine or thymine with a lysine or an arginine as a linker have been synthesized and its potential as the inhibitor for HIV TAR-Tat interaction examined. Among them, modified neamine having an arginine-nucleobase showed a higher inhibition than that of the one having a lysine-nucleobase. The difference of the nucleobase anchor did not characterize inhibition specificity. Also, stereochemistry of the amino acid in the compounds causes no difference in the inhibition for TAR-Tat.

KW - Aminoglycoside

KW - Drug design

KW - HIV TAR

KW - HIV Tat

KW - Inhibition

KW - Neamine

UR - http://www.scopus.com/inward/record.url?scp=33644769091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644769091&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2005.11.056

DO - 10.1016/j.bmc.2005.11.056

M3 - Article

VL - 14

SP - 2799

EP - 2809

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 8

ER -